In This Section

12th AACR-JCA Joint Conference: Breakthroughs in Cancer Research— Translating Knowledge into Practice

February 5-9, 2022
Hyatt Regency Maui
Maui, Hawaii

Abstract Submission and Award Application DeadlineMonday, November 22, 2021, 12 p.m. ET
Advance Registration DeadlineThursday, December 16, 2021, 12 p.m. ET

AACR Organizing Committee

Antoni Ribas, Cochair, University of California Los Angeles, Jonsson Comprehensive Cancer Center, Los Angeles, California
Alexander Marson, University of California San Francisco, San Francisco, California
Olufunmilayo I. Olopade, UChicago Medicine Comprehensive Cancer Center, Chicago, Illinois
David A. Tuveson, Cold Spring Harbor Laboratory Cancer Center; Lustgarten Foundation, Cold Spring Harbor, New York
Karen H. Vousden, The Francis Crick Institute, London, United Kingdom
Ashani T. Weeraratna, Johns Hopkins University, Baltimore, Maryland
Anna M. Wu, City of Hope, Duarte, California

JCA Organizing Committee

Masanori Hatakeyama, Cochair, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Masanobu Oshima, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
Issei Kitabayashi, National Cancer Center Research Institute, Tokyo, Japan
Toru Hirota, The Cancer Institute Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan
Khay Guan Yeoh, National University of Singapore (NUS), Singapore, Singapore
Naoko Ohtani, Osaka City University Graduate School of Medicine, Osaka, Japan
Junko Takita, Kyoto University, Graduate School of Medicine, Kyoto, Japan

The American Association for Cancer Research (AACR) and Japanese Cancer Association (JCA) are proud to offer this 12th AACR-JCA Joint Conference. This meeting series has a long tradition of bringing together outstanding researchers from the United States, Japan, and around the world to share their findings and present the latest advances in basic, translational, and clinical cancer research. Formal and informal interactions as well as international collaborations are fostered through this unique forum. Just as its predecessors have done, this AACR-JCA Joint Conference will take a broad view of contemporary cancer research and will be of interest to basic, translational, and clinical investigators at all career levels.


#aacrJCA22

Program Topics and Speakers

Keynote Addresses
  • Alexander Marson, University of California San Francisco, San Francisco, California
  • Masanori Hatakeyama, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan
Plenary Session 1: Tumor Microenvironment
  • Ashani T. Weeraratna, Johns Hopkins University, Baltimore, Maryland
  • Naoko Ohtani, Osaka City University Graduate School of Medicine, Osaka, Japan
  • Leah M. Cook, University of Nebraska Medical Center, Omaha, Nebraska
Plenary Session 2: Cancer Genomics and Cancer Evolution
  • Christina Curtis, Stanford University, Stanford, California
  • Junko Takita, Kyoto University, Graduate School of Medicine, Kyoto, Japan
  • Mariam Jamal Hanjani, University College London Cancer Institute, London, United Kingdom
Plenary Session 3: Cancer Immunology
  • Andrea Schietinger, Memorial Sloan Kettering Cancer Center, New York, New York
  • Hiroshi Komoto, Kyoto University, Kyoto, Japan
  • Avery D. Posey, Jr., University of Pennsylvania, Philadelphia, Pennsylvania
Plenary Session 4: Cancer Immunotherapy
  • Antoni Ribas, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California
  • Hiroyoshi Nishikawa, National Cancer Center, Tokyo, Japan
  • Yosuke Togashi, Chiba Cancer Center, Kashiwa, Japan
Plenary Session 5: Preclinical Models; Organoids; Genetic and Transplantation Models
  • David A. Tuveson, Cold Spring Harbor Laboratory Cancer Center; Lustgarten Foundation, Cold Spring Harbor, New York
  • Masanobu Oshima, Kanazawa University, Kanazawa, Japan
  • Meritxell Huch, Max Planck Institute, University of Cambridge, Cambridge, United Kingdom
Plenary Session 6: Epigenetics; Cancer Plasticity and Heterogeneity; RNA Networks
  • Richard A. Young, Whitehead Institute, Cambridge, Massachusetts
  • Issay Kitabayashi, National Cancer Center Research Institute, Tokyo, Japan
  • Daichi Inoue, Institute of Biomedical Research and Innovation, Kobe, Japan
Plenary Session 7: Cancer Metabolomics
  • Karen H. Vousden, The Francis Crick Institute, London, United Kingdom
  • Nobuhiro Tanuma, Miyagi Cancer Center, Miyagi, Japan
  • Tsuyoshi Osawa, The University of Tokyo, Tokyo, Japan
Plenary Session 8: Genomic Instability
  • Paul S. Mischel, Stanford University, Stanford, California
  • Toru Hirota, The Cancer Institute Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan
  • Natsuko Chiba, Tohoku University, Miyagi, Japan
Plenary Session 9: Genetic and Environmental Factors in Carcinogenesis
  • Olufunmilayo I. Olopade, UChicago Medicine Comprehensive Cancer Center, Chicago, Illinois
  • Shumpei Ishikawa, The University of Tokyo, Tokyo, Japan
  • Yukari Totsuka, National Cancer Center, Tokyo, Japan
Plenary Session 10: Early Detection of Cancer
  • John M. Carethers, University of Michigan, Ann Arbor, Michigan
  • Khay Guan Yeoh, National University of Singapore (NUS), Singapore, Singapore
  • Ayuko Hoshino, Tokyo Institute of Technology, Tokyo, Japan
Plenary Session 11: Drug Resistance
  • Katerina Politi, Yale Cancer Center, New Haven, Connecticut
  • Masahiro Sonoshita, Hokkaido University, Hokkaido, Japan
  • Patricia A. Possik, Brazilian National Cancer Institute, Rio de Janerio, Brazil
Plenary Session 12: New Technologies for Cancer Imaging and Other Emerging Technologies
  • Anna M. Wu, City of Hope, Duarte, California
  • Takeaki Ishizawa, The University of Tokyo, Tokyo, Japan
  • Patricia Ribeiro Pereira, Washington University School of Medicine, St. Louis, Missouri


Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available